Immunome, Inc. (IMNM)

Immunome Revenue

In the year 2024, Immunome had annual revenue of $9.04M, down -35.50%. Immunome had revenue of $2.74M in the quarter ending December 31, 2024, a decrease of -28.44%.

• Revenue (ttm): $9.04M
• Revenue Growth: -35.50%
• P/S Ratio: 45.34
• Revenue / Employee: $76,619
• Employees: 118
• Market Cap: 573.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.04M	-4.98M	-35.50%
Dec 31, 2023	14.02M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.